Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/03/024370
CTRI/2020/03/024370
Not yet recruiting
Phase 2

Randomized Controlled trial to evaluate efficacy of Aaragwadhadi Lepa followed by Patolmooladi Kashay orally in dadru w.s.r. T.Corporis

Dr Prajakta Prabhakar Kulkarni0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Sponsor
Dr Prajakta Prabhakar Kulkarni
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Prajakta Prabhakar Kulkarni

Eligibility Criteria

Inclusion Criteria

  • •Patients with the symptoms of Dadru\-
  • •change in colour
  • •erythmatous papulovesicular lesion
  • •Subjects who are willing to involve in the study and give informed consent in written
  • •subjects having positive Microscopic examination of skin scrapping in KOH solution for fungal study

Exclusion Criteria

  • •Any underlying uncontrolled medical illness including diabetes mellitus
  • •hypertension
  • •liver disorder
  • •history of chronic alcoholism
  • •severe cardiovascular and pulmonary disorder (where steroid treatment is required)
  • •cerebral neurological disease
  • •psychiatric diseases
  • •Subjects currently recieving drugs like B\- blockers, antimalarials and NSAIDs or
  • •using corticosteroids and anti\-inflammatory medicines until 15 days before inclusion
  • •into the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Additional synbiotics to combination therapy with immune checkpoint inhibitors for unresectable or recurrent gastric and esophageal cancerGastric cancer , esophageal cancer
JPRN-jRCTs051230063Kurokawa Yukinori244
Not yet recruiting
Phase 2
Ayurvedic Sukhaprasavkar lepa to facilitate Normal childbirth.Health Condition 1: O610- Failed medical induction of labor
CTRI/2024/05/067385one
Not yet recruiting
Phase 3
Study the wound healing effect of ayurvedic medicine on wound of opening of uterusHealth Condition 1: N72- Inflammatory disease of cervix uteri
CTRI/2024/04/065462Dr Archana Subhash Jadhav
Completed
Phase 2
A study to evaluate the efficacy of Kapitthadi lotion as compared to Standard care of treatment on hair loss due to ChemotherapyHealth Condition 1: D099- Carcinoma in situ, unspecified
CTRI/2022/03/041126Dr Prapti Puddatwar50
Completed
Phase 2
Clinical Trial of plant protein source in comparison with whey protein concentrate(80%)
CTRI/2022/08/044843Medizen Labs Pvt Ltd60